MiNK Therapeutics appoints new Principal Financial Officer and Principal Accounting Officer

MiNK Therapeutics, Inc.

Melissa Orilall, VP Global Financial Operations at Agenus, appointed Principal Financial Officer effective March 13, 2026.
Austin Charette, Senior Director Financial Reporting & Compliance at Agenus, appointed Principal Accounting Officer effective same date.
Both provide services via Amended Intercompany Services Agreement with Agenus; no direct compensation from MiNK.
No new arrangements or modifications tied to these designations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.